Leaflet GLUCOTROL XL 5mg modified release tablets

Product code:
W65038001
Quantity:
30
Indicated for:
type 2 diabetes mellitus
Route of administration:
oral
Substance:
glipizide (sulfonylurea antidiabetic)
ATC
A10BB07 — Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Precautions:

Hypoglycemia

Hypoglycemia

This medicine may lower blood sugar.

Glipizide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.

It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Glipizide is effective in reducing the risk of diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).

Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, weight gain, or allergic reactions. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.

General data about GLUCOTROL XL 5mg

Substance:
glipizide
Date of latest medicines list:
01-12-2018
Product code:
W65038001
Concentration:
5mg
Pharmaceutical form:
modified release tablets
Quantity:
30
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
FAREVA AMBOISE - FRANTA
Holder:
PFIZER EUROPE MA EEIG - BELGIA
Number:
12729/2019/01
Shelf life:
3 years

Pharmaceutical forms available for glipizide

Concentrations available for glipizide

  • 10mg
  • 5mg